CompletedNCT01785147
Efficacy and Safety of BP1.4979 in Smoking Cessation
Medication studyAges 18–65FranceAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- VillejuifSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateFebruary 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 219
- Sponsor
- Bioprojet
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- France
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01785147
- Official title
Show the full official title
Randomized Placebo Controlled Trial Assessing the Efficacy and Safety of BP1.4979 in Smoking Cessation
Get this study by email
Recruitment & locations
CompletedVillejuif
Questions about this study
Who is behind this study?
The study sponsor is Bioprojet.
Did this study involve medication?
Yes. The study involved medication, including BP1.4979 and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
